Literature DB >> 22422571

Head and neck squamous cell carcinoma in pregnant women.

Anna M Eliassen1, Samantha J Hauff, Alice L Tang, Dafydd H Thomas, Jonathan B McHugh, Heather M Walline, Jay Stoerker, Jessica H Maxwell, Francis P Worden, Avraham Eisbruch, Michael J Czerwinski, Silvana M Papagerakis, Douglas B Chepeha, Carol R Bradford, David A Hanauer, Thomas E Carey, Mark E Prince.   

Abstract

BACKGROUND: The aim of this study was to investigate oral cancer in pregnant women, a rare but therapeutically challenging patient subset.
METHODS: After institutional review board approval, an EMERSE search was used to identify all women treated at the University of Michigan from 1998 to 2010 with head and neck squamous cell carcinoma (HNSCC) during pregnancy. This identified 4 patients with tongue cancer. Biomarkers and human papillomavirus (HPV) were assessed by immunohistochemistry and multiplex PCR/mass spectrometry, respectively.
RESULTS: Two patients responded well to therapy and are alive more than 10 years after diagnosis; 2 patients died of disease. All tumors overexpressed EGFR and Bcl-xL, 3 of 4 overexpressed c-Met, both tumors that progressed overexpressed p53. All tumors were negative for HPV, p16, estrogen receptor, progesterone receptor, and HER-2.
CONCLUSIONS: Biomarkers of aggressive tumors (high EGFR, c-Met; high Bcl-xL-low p53) did not correlate with outcome. Additional studies are needed to determine whether perineural invasion, delay in diagnosis, and p53 overexpression are factors in poor survival.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22422571      PMCID: PMC3399935          DOI: 10.1002/hed.22973

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  40 in total

1.  Fibroblast-secreted hepatocyte growth factor plays a functional role in esophageal squamous cell carcinoma invasion.

Authors:  Katharine D Grugan; Charles G Miller; Yao Yao; Carmen Z Michaylira; Shinya Ohashi; Andres J Klein-Szanto; J Alan Diehl; Meenhard Herlyn; May Han; Hiroshi Nakagawa; Anil K Rustgi
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-01       Impact factor: 11.205

2.  [Effective therapeutic regimens for patients with triple-negative (ER/PgR/HER2-negative) metastatic breast cancer].

Authors:  Norimichi Kan; Katsuya Kuwata; Keiichi Mise; Hiroshi Kodama
Journal:  Gan To Kagaku Ryoho       Date:  2010-07

3.  Integration of biomarkers including molecular targeted therapies in head and neck cancer.

Authors:  Michelle D Williams
Journal:  Head Neck Pathol       Date:  2010-02-13

Review 4.  C-MET as a new therapeutic target for the development of novel anticancer drugs.

Authors:  I Cañadas; F Rojo; M Arumí-Uría; A Rovira; J Albanell; E Arriola
Journal:  Clin Transl Oncol       Date:  2010-04       Impact factor: 3.405

5.  Optical redox ratio differentiates breast cancer cell lines based on estrogen receptor status.

Authors:  Julie Hanson Ostrander; Christine M McMahon; Siya Lem; Stacy R Millon; J Quincy Brown; Victoria L Seewaldt; Nimmi Ramanujam
Journal:  Cancer Res       Date:  2010-05-11       Impact factor: 12.701

6.  Expression and mutation analysis of her2 in head and neck squamous cell carcinoma.

Authors:  Mahmoud A L Sheikh Ali; Mehmet Gunduz; Esra Gunduz; Ryo Tamamura; Levent Bekir Beder; Naoki Katase; Omer Faruk Hatipoglu; Kunihiro Fukushima; Noboru Yamanaka; Kenji Shimizu; Hitoshi Nagatsuka
Journal:  Cancer Invest       Date:  2010-06       Impact factor: 2.176

7.  EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer.

Authors:  Bhavna Kumar; Kitrina G Cordell; Julia S Lee; Francis P Worden; Mark E Prince; Huong H Tran; Gregory T Wolf; Susan G Urba; Douglas B Chepeha; Theodoros N Teknos; Avraham Eisbruch; Christina I Tsien; Jeremy M G Taylor; Nisha J D'Silva; Kun Yang; David M Kurnit; Joshua A Bauer; Carol R Bradford; Thomas E Carey
Journal:  J Clin Oncol       Date:  2008-05-12       Impact factor: 44.544

8.  Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number.

Authors:  Francis P Worden; Bhavna Kumar; Julia S Lee; Gregory T Wolf; Kitrina G Cordell; Jeremy M G Taylor; Susan G Urba; Avraham Eisbruch; Theodoros N Teknos; Douglas B Chepeha; Mark E Prince; Christina I Tsien; Nisha J D'Silva; Kun Yang; David M Kurnit; Heidi L Mason; Tamara H Miller; Nancy E Wallace; Carol R Bradford; Thomas E Carey
Journal:  J Clin Oncol       Date:  2008-05-12       Impact factor: 44.544

9.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

10.  Advanced oral tongue cancer in a 22-year-old pregnant woman.

Authors:  Esther J Cheung; Henry Wagner; John J Botti; Fred Fedok; David Goldenberg
Journal:  Ann Otol Rhinol Laryngol       Date:  2009-01       Impact factor: 1.547

View more
  6 in total

Review 1.  The impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasis.

Authors:  Josiah Ochieng; Gladys N Nangami; Olugbemiga Ogunkua; Isabelle R Miousse; Igor Koturbash; Valerie Odero-Marah; Lisa J McCawley; Pratima Nangia-Makker; Nuzhat Ahmed; Yunus Luqmani; Zhenbang Chen; Silvana Papagerakis; Gregory T Wolf; Chenfang Dong; Binhua P Zhou; Dustin G Brown; Anna Maria Colacci; Roslida A Hamid; Chiara Mondello; Jayadev Raju; Elizabeth P Ryan; Jordan Woodrick; A Ivana Scovassi; Neetu Singh; Monica Vaccari; Rabindra Roy; Stefano Forte; Lorenzo Memeo; Hosni K Salem; Amedeo Amedei; Rabeah Al-Temaimi; Fahd Al-Mulla; William H Bisson; Sakina E Eltom
Journal:  Carcinogenesis       Date:  2015-06       Impact factor: 4.944

Review 2.  Oral epithelial stem cells - implications in normal development and cancer metastasis.

Authors:  Silvana Papagerakis; Giuseppe Pannone; Li Zheng; Imad About; Nawar Taqi; Nghia P T Nguyen; Margarite Matossian; Blake McAlpin; Angela Santoro; Jonathan McHugh; Mark E Prince; Petros Papagerakis
Journal:  Exp Cell Res       Date:  2014-05-05       Impact factor: 3.905

3.  Estrogen and Progesterone hormone receptor expression in oral cavity cancer.

Authors:  M Grimm; T Biegner; P Teriete; S Hoefert; M Krimmel; A Munz; S Reinert
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2016-09-01

Review 4.  Supraglottic p16+ squamous cell carcinoma during pregnancy: a case report and review of the literature.

Authors:  Jakob Pugi; Marc Levin; Michael Gupta
Journal:  J Otolaryngol Head Neck Surg       Date:  2019-10-15

5.  Treatment of oral cancers during pregnancy: a case-based discussion.

Authors:  Kiyoshi Sato; Hiroaki Shimamoto; Yumi Mochizuki; Hideaki Hirai; Hirofumi Tomioka; Risa Shimizu; Eriko Marukawa; Haruhisa Fukayama; Ryoichi Yoshimura; Hiroo Ishida; Hiroyuki Harada
Journal:  J Otolaryngol Head Neck Surg       Date:  2019-02-04

6.  Obstetrical Outcomes of Head and Neck (Nonthyroid) Cancers: A 27-Year Retrospective Series and Literature Review.

Authors:  Ernesto Antonio Figueiró-Filho; Richard P Horgan; Nidal Muhanna; Jacqueline Parrish; Jonathan C Irish; Cynthia V Maxwell
Journal:  AJP Rep       Date:  2019-01-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.